Published in J Allergy Clin Immunol on May 01, 1990
A self-rating scale for patient-perceived side effects of inhaled corticosteroids. Respir Res (2006) 0.85
Dose-proportional pharmacokinetics of budesonide inhaled via Turbuhaler. Br J Clin Pharmacol (1999) 0.83
Equivalent lung deposition of budesonide in vivo: a comparison of dry powder inhalers using a pharmacokinetic method. Br J Clin Pharmacol (2005) 0.79
Effects of local and systemic budesonide on allergen-induced airway reactions in the pig. Br J Pharmacol (1996) 0.77
Engineering Problems in the Use of Glycol Vapors for Air Sterilization. Am J Public Health Nations Health (1944) 3.52
Epidemiologic Observations on the Use of Glycol Vapors for Air Sterilization. Am J Public Health Nations Health (1945) 2.46
Use of spacers to facilitate inhaled corticosteroid treatment of asthma. Am Rev Respir Dis (1984) 2.35
Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis (1992) 2.02
A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol (1977) 1.43
Clinical use of spacer systems for corticosteroid inhalation therapy: a preliminary analysis. Eur J Respir Dis Suppl (1982) 1.37
Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis (1990) 1.31
Inhibitor of drug-protein binding in "Vacutainers". Lancet (1976) 1.28
Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin. J Clin Endocrinol Metab (1991) 1.21
Passive smoking and low birthweight. Lancet (1989) 1.21
Budesonide: a new corticosteroid in bronchial asthma. Eur J Respir Dis (1980) 1.19
Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man. Eur J Clin Pharmacol (1982) 1.18
Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden. Respir Med (1998) 1.09
Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover. Eur J Clin Pharmacol (1991) 1.07
An evaluation of the workplace smoking bylaw in the city of Toronto. Am J Public Health (1993) 1.06
Dosing regimen of budesonide and occurrence of oropharyngeal complications. Eur J Respir Dis (1984) 1.06
Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man. Eur J Respir Dis Suppl (1982) 1.04
Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma. J Allergy Clin Immunol (1995) 1.03
Multivariate statistical models for predicting change in smoking behavior following physician advice to quit smoking. Prev Med (1982) 1.02
A double-blind study of disodium cromoglycate for prophylaxis of bronchial asthma. Am Rev Respir Dis (1971) 1.02
The effects of counseling on smoking cessation among patients hospitalized with chronic obstructive pulmonary disease: a randomized clinical trial. Int J Addict (1991) 1.02
A population survey on legislative measures to restrict smoking in Ontario: 2. Knowledge, attitudes, and predicted behavior. Am J Prev Med (1988) 1.01
Utility of behavioral self-help manuals in a minimal-contact smoking cessation program. Int J Addict (1981) 0.98
Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid. Clin Pharmacol Ther (1976) 0.98
The health risks of passive smoking. The growing case for control measures in enclosed environments. Chest (1983) 0.97
Change in smoking status among a cohort of late adolescents: prediction and explanation of initiation, maintenance and cessation. Int J Epidemiol (1986) 0.97
Adjunct therapy in chronic obstructive pulmonary disease. Am J Med (1973) 0.97
Particulates in domestic premises. II. Ambient levels and indoor-outdoor relationships. Arch Environ Health (1975) 0.95
Interaction of glucocorticoids and bronchodilators on isolated guinea pig tracheal and human bronchial smooth muscle. Am Rev Respir Dis (1974) 0.95
Albuterol via Turbuhaler versus albuterol via pressurized metered-dose inhaler in asthma. Ann Allergy Asthma Immunol (1997) 0.94
Concentration dependent plasma protein binding of salicylate in rheumatoid patients. Clin Pharmacokinet (1979) 0.94
Assessment of the systemic effects of inhaled glucocorticosteroids: the influence of blood sampling technique and frequency on plasma cortisol and leucocytes. Eur J Clin Pharmacol (1990) 0.93
Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler. J Allergy Clin Immunol (1997) 0.93
Pharmacological study of adenosine and related compounds on isolated guinea pig trachea: evidence for more than one type of purine receptor. Can J Physiol Pharmacol (1980) 0.93
The addition of an aerosol anticholinergic to an oral beta agonist plus theophylline in asthma and bronchitis. A double-blind single dose study. Chest (1982) 0.93
Multivariate prediction of smoking cessation following physician advice to quit smoking: a validation study. Prev Med (1983) 0.92
First pass hydroxylation of nortriptyline: concentrations of parent drug and major metabolites in plasma. Eur J Clin Pharmacol (1977) 0.92
Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol (1982) 0.90
Respiratory smooth muscle relaxing effect of commercial steroid preparations. Am Rev Respir Dis (1973) 0.88
Minimum dose requirements of steroid-dependent asthmatic patients for aerosol beclomethasone and oral prednisone. J Allergy Clin Immunol (1978) 0.88
Importance of duration of treatment with inhaled budesonide on the immediate and late bronchial reaction. Eur J Respir Dis Suppl (1982) 0.88
Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. J Allergy Clin Immunol (1989) 0.88
Portable Glycol Vaporizers for Air Disinfection. Science (1947) 0.87
Psychological effects of an exercise program for post-infarct and normal adult men. J Sports Med Phys Fitness (1967) 0.87
Does cigarette smoking affect the fitness of young adults? Rationale and protocol for future research. J Sports Med Phys Fitness (1992) 0.86
Plasma protein binding, plasma concentrations, and effects of diphenylhydantoin in man. Ann N Y Acad Sci (1971) 0.86
Predictability of the clinical potency of NSAIDs from the preclinical pharmacodynamics in rats. Inflamm Res (1996) 0.86
A population survey on legislative measures to restrict smoking in Ontario: 3. Variables related to attitudes of smokers and nonsmokers. Am J Prev Med (1990) 0.85
Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma. J Allergy Clin Immunol (1993) 0.85
The effects of ephedrine on the physiological and psychological responses to submaximal and maximal exercise in man. Med Sci Sports (1977) 0.85
Comparison of hypnosis plus counseling, counseling alone, and hypnosis alone in a community service smoking withdrawal program. J Consult Clin Psychol (1975) 0.84
Airways narrowing in exercise in normal subjects and the effect of disodium cromoglycate. Br J Dis Chest (1973) 0.84
Pharmacokinetics of estramustine phosphate (Estracyt) in prostatic cancer patients. Eur J Clin Pharmacol (1984) 0.84
Intensity of follow-up. Effects on estimates in a population telephone survey with an extension of Kish's (1965) approach. Am J Epidemiol (1988) 0.84
Passive smoking. Acute effects in asthma. Chest (1986) 0.84
Plasma protein binding of propranolol in disease states [proceedings]. Br J Clin Pharmacol (1977) 0.84
Four-times-a-day dosing frequency is better than a twice-a-day regimen in subjects requiring a high-dose inhaled steroid, budesonide, to control moderate to severe asthma. Am Rev Respir Dis (1989) 0.83
The time course of maximum ventilatory performance during and after moderately heavy exercise. Clin Sci (1969) 0.83
Chronic respiratory disease in four occupational groups. Arch Environ Health (1974) 0.83
Serum osteocalcin and procollagen as markers for the risk of osteoporotic fracture in corticosteroid-treated asthmatic adults. J Allergy Clin Immunol (1999) 0.83
The prevalence of chronic respiratory disease in the male physicians of London, Ontario. Can Med Assoc J (1970) 0.82
A population survey in Ontario regarding restrictive measures on smoking: relationship of smoking status to knowledge, attitudes and predicted behaviour. Int J Epidemiol (1987) 0.82
Variations in the relative potencies of bronchodilators in the presence and absence of carbachol-induced tone. Can J Physiol Pharmacol (1974) 0.82
Single-dose inhaled budesonide in subjects with chronic asthma. Allergy (1991) 0.82
Acute dose-response studies in bronchial asthma with a new corticosteroid, budesonide. Br J Clin Pharmacol (1983) 0.81
The role of health beliefs in compliance with physician advice to quit smoking. Soc Sci Med (1984) 0.81
Systemic effects of two nasally administered glucocorticosteroids. Allergy (1997) 0.81
Prescribing of minor tranquillizers for emotional problems in a family practice. Can Med Assoc J (1981) 0.80
Effect on lung function of budesonide by inhalation, terbutaline s.c. and placebo given simultaneously or as single treatments. Eur J Respir Dis Suppl (1982) 0.80
Impairment of estramustine phosphate absorption by concurrent intake of milk and food. Eur J Clin Pharmacol (1990) 0.80
A psychological and behavioural comparison of ex-smokers and smokers. J Chronic Dis (1976) 0.80
Cross-sectional analysis of variables related to cigarette smoking in late adolescence. J Drug Educ (1985) 0.79
Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers. Int J Clin Pharmacol Ther (2006) 0.79
Methodological aspects on clinical trials with inhaled corticosteroids: results of two comparisons between two steroid aerosols in patients with asthma. Eur J Respir Dis Suppl (1982) 0.79
A clinical trial of combined cromolyn/beclomethasone treatment for chronic asthma. J Allergy Clin Immunol (1981) 0.79
A population survey on legislative measures to restrict smoking in Ontario: 1. Design, methodology, and sample representativeness. Am J Prev Med (1988) 0.78
Comparison of mail questionnaire and telephone interview as data gathering strategies in a survey of attitudes toward restrictions on cigarette smoking. Can J Public Health (1985) 0.78
Exposure to environmental tobacco smoke (ETS) and serum thiocyanate level in infants. Arch Environ Health (1990) 0.78
Analgesia duration and physical dependence in mice after a single injection of three heroin salts and morphine sulphate in various vehicles. Arch Int Pharmacodyn Ther (1978) 0.78
An objective measure of the validity of children's responses to a questionnaire on health and smoking. Can J Public Health (1978) 0.77
Airway and lung elastic fibre is not reduced in asthma nor in asthmatics following corticosteroid treatment. Eur Respir J (1995) 0.77
Pulmonary uptake of technetium-99m-sestamibi induced by dipyridamole-based stress or exercise. J Nucl Med (1998) 0.77
Change in smoking status among school-aged youth: impact of a smoking-awareness curriculum, attitudes, knowledge and environmental factors. Am J Public Health (1981) 0.77
The hydrolysis of estramustine phosphate; in vitro studies. Eur J Drug Metab Pharmacokinet (1984) 0.77
Distribution and metabolism of estramustine in HeLa cells and the human prostatic tumour cell line 1013L. Biochem Pharmacol (1988) 0.77
Reactions of 4beta,5-epoxy-5beta-androstan-3-ones with hydrogen fluoride in pyridine. Steroids (1978) 0.76
A clinical index of disability due to chronic asthma tested during a trial of cromolyn sodium treatment. Chest (1973) 0.76
Short- and long-term prediction of self-reported cigarette smoking in a cohort of late adolescents: report of an 8-year follow-up of public school students. Prev Med (1987) 0.76
In vitro studies of microwave-induced cataract: reciprocity between exposure duration and dose rate for pulsed microwaves. Exp Eye Res (1985) 0.76
Attitudes of patients with chronic respiratory disease to smoking cessation. Can Fam Physician (1988) 0.75
Voluntary ethanol consumption in the rat following peripheral administrations of 3-carboxy-salsolinol. Subst Alcohol Actions Misuse (1980) 0.75
Smoking cessation among pulmonary patients as related to type of respiratory disease and demographic variables. Can J Public Health (1980) 0.75